Revelation Biosciences (NASDAQ:REVBW – Get Free Report) is expected to be issuing its results before the market opens on Friday, August 7th. Analysts expect the company to announce earnings of ($0.83) per share for the quarter.
Revelation Biosciences Stock Performance
Shares of REVBW stock opened at $0.01 on Thursday. Revelation Biosciences has a 52-week low of $0.01 and a 52-week high of $0.04. The business’s fifty day moving average is $0.01 and its 200 day moving average is $0.01.
Revelation Biosciences Company Profile
Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.
The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.
Featured Stories
- Five stocks we like better than Revelation Biosciences
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
